Latest Post

January 21, 2021

West's Envision™ Verification System – Risk Mitigation for Quality of Drug Product

One factor of parenteral drug product quality is the container closure integrity (CCI) of the primary packaging system. The interaction between the sealing surface of the elastomeric component and the vial is vital to ensure stability of the drug product over the shelf life. Therefore, defects found on the elastomeric component can increase the risk of failure or end-of-the-line rejects.
Cathy Chhour

Cathy Chhour

Sr. Specialist, Regulatory Affairs


Search the Blog





  • Previous Posts
    Plungers Vision Inspection

    June 26, 2018

    Inspecting Elastomer Components: Can You Spot a Defect?

    Bill Matakas

    Bill Matakas

    Sr. Director, Product Management & Marketing Operations